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T he incidence of life-threatening fungal infections has increased steadily over the past 2 decades as a result of an increase in the number of susceptible immunosuppressed patients (39, 68) . However, there are a limited number of antifungals available that can safely and effectively treat serious invasive fungal infections in humans. Drugs available for human invasive fungal infections are represented principally by four classes of compounds-polyenes, fluorinated pyrimidines, azoles, and echinocandins-but they each have limited usefulness because of their limited spectrum of antifungal activity, adverse effects, drug-drug interactions, variable pharmacokinetics (often requiring therapeutic drug monitoring), and/or only one type of formulation (12) . Resistance is also becoming an increasing problem, particularly among members of the azole class (33, 44, 45, 47, 66) . Therefore, new antifungal drugs with novel mechanisms of action which show no crossresistance to existing antifungals are desirable for the treatment of serious invasive fungal infections.
We have also focused our attention on ways to interfere with the expression of virulence factors that are associated with the establishment of fungal infections in order to design an optimal novel antifungal agent. Microorganisms must first attach to host cell surfaces in order to establish infections; this is followed by colonization and replication on these host mucosal or endothelial surfaces and then by pathogen penetration across one or more mucosal barriers or by systemic dissemination through the intravascular route. Some of the fungal ligands (adhesins) responsible for the adhesion step are derived from glycosylphosphatidylinositol (GPI)-anchored proteins. For example, Candida albicans, which is one of the most common fungal pathogens encountered in the clinical setting, is estimated to possess 115 GPI-anchored proteins (51) . Some GPI-anchored proteins are known to be transported to the cell wall and then function as adhesins (7) . The Als protein family members are typical GPI-anchored proteins. Inhibition of GPI-anchored-protein maturation is a promising therapeutic goal for the treatment of fungal infections.
In the course of screening compounds that inhibit the cell wall assembly of GPI-anchored proteins, we discovered the GWT1 gene (63) , which encodes an inositol acyltransferase found early in the GPI biosynthesis pathway (36, 64) , and this led to the creation of an inhibitor of this enzyme, 1-(4-butylbenzyl)isoquinoline (BIQ) (63) . In our efforts to improve the efficacy of this prototype-inhibitor BIQ (38, 59) , we next developed E1210, 3-(3-{4-[(pyridin-2yloxy)methyl]benzyl}isoxazol-5-yl)pyridin-2-amine (34) . This compound showed potent in vitro antifungal activity against a broad range of pathogenic fungi, including Candida spp., Aspergillus spp., and other molds, such as Fusarium and Scedosporium spp., although its action was fungistatic (34) , and subsequently showed high therapeutic efficacy in several representative in vivo models of invasive fungal infections (19) .
In this study, we investigated the inhibitory activity of E1210 on the inositol acylation of GPI, and we showed that the mechanism of action of E1210, inositol acyltransferase inhibition in the GPI biosynthesis pathway, involved selective inhibition of fungal but not human enzymes. In addition, we investigated the effects of E1210 on the expression of the ALS1 protein (Als1p), a GPI-anchored protein, on the cell surface of C. albicans and on virulence factors of C. albicans: germ tube formation, adherence, and biofilm formation. There is a possibility that the GWT1 protein (Gwt1p) inhibitors might prove useful for the treatment of infections due to other microbes.
(This study was presented in part at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, 12 to 15 September 2010.) (1% yeast extract, 2% Bacto peptone, 2% sucrose, and 1.2% Bacto agar), and RPMI 1640 medium (Nissui Pharmaceutical Co., Tokyo, Japan) buffered with 0.165 M 3-morpholinopropane sulfonic acid (MOPS) (pH 7.0) (MOPS-RPMI 1640) were used, and for germ tube formation assay of C. albicans, yeast nitrogen base with amino acids supplemented with 0.5% glucose (YNB), Spider medium (31), Lee's medium (28) , YPD broth (Becton Dickinson Company) supplemented with 10% fetal calf serum (FCS), and yeast nitrogen base without amino acids but supplemented with 2.5 mM N-acetylglucosamine (35) were also used. Mueller-Hinton broth (MHB; Becton Dickinson Company) was used for bacteria.
MIC determinations. The MICs of all compounds were determined using a broth microdilution method in accordance with the guidelines presented in Clinical and Laboratory Standards Institute (CLSI) documents M27-A3 for yeasts (9) and M07-A7 for bacteria (8) . Inoculum sizes were 1 ϫ 10 3 for S. cerevisiae and C. albicans and 5 ϫ 10 5 cells/ml for bacteria. After 48 h at 30°C for S. cerevisiae and at 35°C for C. albicans, or after 18 h at 35°C for bacteria, MICs were read. The MICs of E1210 were defined as the lowest concentration at which a prominent decrease (Ն50% of the growth of the compound-free control) in growth turbidity relative to the turbidity of the compound-free control at 660 nm was observed. The MICs of other compounds were read in accordance with the CLSI guidelines.
Preparation of yeast membrane fractions. The membrane fractions of S. cerevisiae GWT1 disruptant harboring YEp-Ca, YEp-Af, or YEp-hum were used as the enzyme sources because the Gwt1p activity in membrane fractions of C. albicans and A. fumigatus cells was low. Yeast cells grown in SD(ϪUra) medium were then harvested by centrifugation, washed twice in 50 mM Tris-HCl buffer (pH 7.5) containing 2 mM MgCl 2 (TM buffer), and suspended in TM buffer with 0.1% 2-mercaptoethanol. The cell suspensions were mixed with an equal weight of glass beads (diameter, 0.5 mm), and were homogenized with a cell disruptor [Multi Beads Shocker, model MB601(S); Yasui Kikai Co., Osaka, Japan] operating at 2,500 rpm with 12 cycles of 30-s bursts and 30-s intervals at 0°C. The unbroken cells and glass beads were removed by centrifugation at 3,000 ϫ g for 5 min at 4°C. The supernatants were further centrifuged at 20,000 ϫ g for 20 min at 4°C, and the pellets were washed with TM buffer. The pellets were resuspended in TM buffer containing 10% glycerol and used as the membrane fraction. The protein concentration was estimated by a Coomassie Plus-The Better Bradford assay kit (Pierce Biotechnology Inc., Rockford, IL) with bovine serum albumin as the standard. The membrane fractions were diluted with TM buffer to 1 mg of protein/ml. They were stored at Ϫ80°C until use.
In vitro assay for the inositol acylation in GPI biosynthesis. Inositol acylation was assayed by the method of Umemura et al. (64) with slight W303-1A  MAT-a ade2-1 his3-11 leu2-3,112 trp1-1 ura3-1 can1-100  W303-1B  MAT-␣ ade2-1 his3-11 leu2-3,112 trp1-1 ura3-1 can1-100  W303D  MATa/␣ ade2-1/ade2-1 his3-11/his3-11 leu2-3,112/leu2-3,112 trp1-1/trp1-1 ura3-1/ura3-1 can1-100/can1-100  WDG2 MAT-a/␣ ade2-1/ade2
MAT-␣ ade2-1 his3-11 leu2-3,112 trp1- (10) . In this solvent system, the order of migration of PI-GlcNAc and PI-GlcN is the reverse of that achieved in the CHCl 3 -CH 3 OH-1 M NH 4 OH (10:10:3) solvent system which Umemura et al. used (64) . Then attached to BAS-MS2040 imaging plates (Fujifilm Co., Tokyo, Japan) for 2 to 5 days for autoradiography. Radioactive products were detected and analyzed with a BAS2500 imaging analyzer (Fujifilm), and the photostimulated luminescence counts of the acylated phosphatidylinositol glucosamine [PI (acyl)-GlcN] zones were quantified. The positions of the radioactive PI (acyl)-GlcN zones were identified as those that were not detected in the absence of palmitoyl-CoA. Each experiment was carried out three times. The inhibition rate (percent) of the inositol acylation of GPI at each compound concentration was calculated, and the mean 50% inhibitory concentration (IC 50 ) and 95% confidence interval (CI) were determined. Phosphatidylinositol-specific phospholipase C (PI-PLC) treatment of radiolabeled lipids was conducted according to the method of Umehara et al. (64) .
Als1p protein levels. To estimate the amount of Als1p expressed on the cell surface, the compound-treated cells were retained on the filters, and the relative Als1p levels on the cell surface of cells were measured with an enzyme-linked immunosorbent assay (ELISA). C. albicans IFM49971 was grown in SDB for 3 days at 25°C without shaking, to obtain a saturated culture containing synchronized cells (20) . The culture was centrifuged at 800 ϫ g for 5 min at 4°C to pellet the cells, and the pellet was then resuspended in MOPS-RPMI 1640 medium at a concentration of 5 ϫ 10 6 cells/ml. Since Fu et al. (15) showed that the Als1p expression on the surface of C. albicans cells was induced after incubation for 1 h in MOPS-RPMI 1640, C. albicans cells were incubated for 1 h at 35°C in MOPS-RPMI 1640 that contained serial fourfold dilutions of E1210, micafungin, or fluconazole on a filter plate (MultiScreen HTS 96-well filtration plate; Millipore Corp., Billerica, MA). Compound-free controls (controls) and C. albicans-free controls (blanks) were included. Little change in cell counts was observed after treatment with E1210, micafungin, or fluconazole for 1 h. The concentrations used were 1/4ϫMIC, 1ϫMIC, 4ϫMIC and 16ϫMIC of each compound. The assay for each concentration for each compound was performed in sextuplicate and repeated three times. After incubation for 1 h, the medium was removed by using a vacuum manifold. The C. albicans cells remaining on the filter were washed three times by aspiration with phosphate-buffered saline (PBS) and then were assayed by ELISA. For the ELISA, 4-fold-diluted Block Ace solution (Snow Brand Milk Products Co., Hokkaido, Japan) was used as the blocking agent, anti-Als1 rabbit polyclonal antibody (Sawady Technology Co., Tokyo, Japan) was used as the primary antibody, and anti-rabbit IgG, horseradish peroxidase (HRP)-linked donkey antibody (GE Healthcare UK Ltd., Buckinghamshire, England) was used as the secondary antibody. The amount of Als1p was estimated based on peroxidase activity, which was assayed on filter plate after the addition of 0.1 ml SureBlue Reserve TMB microwell peroxidase substrate (KPL Inc., Gaithersburg, MD) as the substrate. The plates were incubated for 15 min at room temperature, and the reaction was terminated by adding 0.1 ml TMB stop solution (KPL). The reaction mixture was filtered, and the absorbance of each filtrate was measured at 450 nm. The Als1p expression rate (percentage of the control) was then calculated. The expression levels of Rho1p, a membrane protein without a GPI anchor, on the cell surface were likewise evaluated using the ELISA method.
The Als1p levels in crude extracts of C. albicans cells were also determined. The cells were incubated for 1 h at 35°C in the presence of E1210. After incubation, the cultures were centrifuged at 1,000 ϫ g for 10 min at 4°C and the pellets were suspended in 50 mM potassium phosphate buffer (pH 7.4) containing a protease inhibitor cocktail for fungi (Sigma-Aldrich). The cell suspensions were mixed with an equal weight of glass beads and were homogenized with the cell disruptor. The unbroken cells and glass beads were then removed by centrifugation. The supernatants were obtained as crude extracts. The amount of Als1 protein in the crude extracts was also measured by an ELISA. Anti-Als1 antibody was used as the capture antibody, and anti-C. albicans, HRP-conjugated rabbit antibody (ViroStat Inc., Portland, ME) was used as the secondary antibody. An ELISA of each concentration was conducted in duplicate, and the final values were expressed as the means of three determinations. Protein concentration was estimated in order to standardize the amount of Als1p.
Adherence and germ tube formation in C. albicans. Cells grown in SDB for 3 days at 25°C were resuspended to concentrations of 5 ϫ 10 6 and 1 ϫ 10 6 cells/ml in MOPS-RPMI 1640 for the adherence assay and the germ tube formation assay, respectively. C. albicans cells were incubated at 35°C in MOPS-RPMI 1640 that contained serial 2-fold dilutions of E1210, fluconazole, micafungin, or amphotericin B. The number of C. albicans cells that adhered to the wells of 96-well polystyrene plates was determined using the crystal violet staining assay (1). Compound-free controls (controls) and C. albicans-free controls (blanks) were included. The plates were incubated for 1 h and 4 h for the adherence assay and the germ tube formation assay, respectively. The latter assay is based on the observation that C. albicans germ tubes adhere to plastic surfaces (1, 62) . However, incubation for Ͼ1 h in MOPS-RPMI 1640 induces germ tube formation in C. albicans cells; it is therefore difficult to compare the inhibitory effects of compounds on C. albicans adherence with and without the potential to inhibit germ tube formation in C. albicans cells after Ͼ1 h incubation. Thus, to evaluate the inhibitory effects of compounds on the adherence of C. albicans cells, they were incubated for 1 h, at which time point no distinct cell elongation was apparent (see Fig. 7 ). In addition, to investigate the adherence potential of C. albicans cells that were not cultured in MOPS-RPMI 1640, plates that included only controls and blanks were also prepared and were immediately subjected to the procedures described below.
After incubation, the plates were processed by the procedures of Brayman and Wilks (5) . The medium in the plates was discarded by inverting the plates. The remaining C. albicans cells in the wells were sterilized by immersion in 70% ethanol, which was discarded, and then 0.2 ml of 0.25% sodium dodecyl sulfate (SDS) (Wako Pure Chemical Industries, Osaka, Japan) was added to each well. The SDS was discarded, and the plates were washed three times by immersion in ion-exchanged water. The C. albicans cells that attached to the wells were stained for 20 min at room temperature with 0.1 ml of 0.02% crystal violet (Muto Pure Chemicals Co., Tokyo, Japan) diluted with PBS. The crystal violet solution was removed by inverting the plates. They were then washed three times with water, once with 0.25% SDS, and twice again with water. After the plates were dried, 0.2 ml isopropanol containing 40 mM HCl and 0.05 ml of 0.25% SDS were added to the wells, and the absorbance at 590 nm was measured using a 660-nm reference. The absorbance of each concentration for each compound was measured in duplicate, and the final values were expressed as the means of three determinations. The adherence rate and the germ tube formation rate (percentage of the control) were each calculated, and the mean IC 50 and 95% CI were calculated. An additional plate was prepared for each assay, and after incubation, 0.05 ml of 3% glutaraldehyde solution (Wako Pure Chemical Industries) was added to the culture wells to fix the cells. After fixation, the C. albicans cells were observed by phase-contrast microscopy and the microscopic images of culture wells were each recorded. Effects of E1210 on germ tube formation were also evaluated in YNB, Spider medium, Lee's medium, YPD supplemented with 10% FCS, and yeast nitrogen base without amino acids but supplemented with 2.5 mM N-acetylglucosamine.
Colony morphology. Cells grown in SDB for 3 days at 25°C were resuspended and diluted to 1 ϫ 10 4 cells/ml in physiological saline. Approximately 100 cells were mixed with molten YPS agar that contained serial 2-fold dilutions of E1210 and plated. Plates were incubated for 48 h at 35°C, and colonies were microscopically observed.
Biofilm formation in C. albicans. The 96-well microtiter plates were pretreated with 0.1 ml of FCS for 24 h at 35°C and washed twice in PBS. C. albicans IFM49971 grown in SDB for 3 days at 25°C without shaking was resuspended in MOPS-RPMI 1640 supplemented with 10% FCS. Then, 0.1 ml C. albicans cell suspension (1 ϫ 10 6 cells/ml) was added. The plates were incubated for 1 h at 35°C. The medium was discarded by inverting the plates. The plates were washed three times with PBS to remove any unattached planktonic cells. Compound dilutions in MOPS-RPMI 1640 supplemented with 10% FCS were dispensed into a microtiter plate.
Compound-free controls (controls) and C. albicans-free controls (blanks) were included. After incubation for 24 h at 35°C, the plates were stained using safranin. Safranin is capable of staining exopolymeric material structures (53, 54) ; therefore, biofilm formation was evaluated by determining the biofilm density after safranin staining. The biofilms were stained for 15 min at room temperature by adding 50 l of 1% safranin solution (Waldeck GmbH & Co. KG, Münster, Germany). The safranin solution was carefully removed by aspiration, and the wells were washed carefully three times with PBS. Then, 0.2 ml DMSO was added to the wells and mixed gently. Absorbance at 492 nm was measured using a 660-nm reference. Each concentration for each compound was performed in duplicate, and the final values were expressed as the means of three determinations. The biofilm density (% of control) was calculated, and the mean IC 50 and the 95% CI were also calculated.
MICs for sessile forms (SMICs) of C. albicans were also determined according to the method of Jacobson et al. (24) . C. albicans strains grown in yeast nitrogen base medium were suspended in MOPS-RPMI 1640 at a concentration of 1 ϫ 10 7 CFU/ml. Each suspension (0.1 ml) was added to the 96-well microtiter plate and incubated at 35°C. After incubation for 24 h, the suspensions were discarded, and the wells were rinsed three times with PBS and filled with 0.1 ml of compound dilutions in MOPS-RPMI 1640. Microtiter plates were incubated at 35°C for an additional 48 h. Then, media were discarded, and wells were rinsed three times with PBS. The metabolic activity of C. albicans cells was measured using the XTT [2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide; Sigma-Aldrich] reduction assay, in which a colorimetric change should correlate directly with the metabolic activity of the C. albi- cans cells (4, 48) . XTT was prepared as a saturated solution at 0.5 mg/ml in PBS. Prior to the assay, stock XTT solution was thawed, and menadione (10 mM in acetone; Sigma-Aldrich) was added to give a final concentration of 25 M. XTT-menadione solution was then added to the plates, and the plates were incubated in the dark for 30 min at 35°C. The colorimetric change was measured at 492 nm using a 660-nm reference. The SMICs were defined as the lowest concentrations associated with a 50% reduction in absorption compared to the absorption level for the control. MICs for planktonic forms were determined using broth microdilution (9) .
Scanning electron microscopy. A four-well slide (Sonic Seal Slide Wells; Nalge Nunc International Corp., Rochester, NY) was pretreated with 1 ml of FCS for 24 h at 35°C and washed twice with PBS. Then, the C. albicans cells (1 ϫ 10 6 cells) suspended in MOPS-RPMI 1640 were added, and the slide was incubated for 1 h at 35°C. The medium was then discarded, and the slide was washed three times with PBS to remove unattached planktonic cells. Then, 1 ml of MOPS-RPMI 1640 supplemented with 10% FCS containing E1210 (0.008 g/ml) was added. After incubation for 24 h at 35°C, 1 ml of 2% glutaraldehyde solution was added to the culture wells to fix the cells. After 1 h of fixation, the C. albicans cells in biofilms were carefully rinsed four times with PBS and then placed in 1% osmium tetroxide for 1 h. The specimens were subsequently dehydrated in a series of ethanol washes, treated with isoamyl acetate overnight, and finally dried by a critical-point drying method. The specimens were then coated with gold. After the specimens were processed, they were examined under a scanning electron microscope (Type JSM-820; JEOL Ltd., Tokyo, Japan).
Statistical analysis. Statistical analyses were performed using the SAS software package, version 8.2 (SAS Institute Japan Ltd., Tokyo, Japan), for the Als1p and Rho1p expression levels.
Nucleotide sequence accession numbers. The CaGWT1 and Af-GWT1 genes were deposited in GenBank under accession numbers AB092481 and AB092482, respectively.
RESULTS
In vitro inositol acylation of GPI. Figure 1 shows a representative autoradiograph of the thin-layer chromatography (TLC) separation observed in the assay of GPI inositol acylation with E1210 and the other antifungals. Radiolabeled PI (acyl)-GlcN was detected as a product of the inositol acylation of GPI in the membrane fractions of S. cerevisiae cells that overexpressed CaGwt1p, AfGwt1p or Pig-Wp. E1210 inhibited the production of PI (acyl)-GlcN by CaGwt1p and AfGwt1p in a concentration-dependent manner, indicating that the compound inhibited an early step of the GPI biosynthesis pathway of C. albicans and A. fumigatus. The IC 50 s of E1210 for inositol acylation by CaGwt1p and AfGwt1p were 0.27 M (0.097 g/ml) (95% CI, 0.18 to 0.39 M) and 0.60 M (0.22 g/ml) (95% CI, 0.24 to 1.5 M), respectively. In contrast, E1210 had no effect on inositol acylation by human Gwt1p even at 100 M (36 g/ml). Fluconazole, amphotericin B, and micafungin had little or no effect on inositol acylation based on all Gwt1ps tested, each yielding IC 50 s of Ͼ100 M.
MICs of E1210 for ScGWT1-disrupted S. cerevisiae strains harboring plasmids YEp-Ca and pRS-Ca were 0.03 and 0.25 g/ml, respectively. The MICs for ScGWT1-disrupted S. cerevisiae strains harboring plasmids YEp-Af and pRS-Af were 0.5 and 2 g/ml, respectively. Overexpression of fungal GWT1 proteins reduced the activity of E1210 4-to 8-fold. The MIC of E1210 was Ͼ32 g/ml for S. cerevisiae harboring plasmid YEp-hum. No differences in MICs of fluconazole (4 g/ml), micafungin (0.06 g/ml), and amphotericin B (4 g/ml) for strains tested were observed. In addition, E1210 showed no antibacterial activity against E coli IFO12734 and S. aureus IFO12732 (MICs, Ͼ32 g/ml) since they do not possess any GPI biosynthetic pathway, and the IC 50 of E1210 for human HK-2 cells was Ͼ32 g/ml (34) . These results suggested that E1210 inhibits the inositol acylation of GPI catalyzed by fungal GWT1 proteins but not by human PIG-W protein.
Als1 expression levels. We evaluated the expression levels of Als1p on the cell surface of C. albicans cells treated with E1210 because the compound was expected to inhibit the maturation of GPI-anchored proteins. Als1p expression on the surface of C. albicans IFM49971 cells grown for 1 h in MOPS-RPMI 1640 was induced as reported by Fu et al. (15) . E1210 suppressed this induction in a concentration-dependent manner (Fig. 2) . E1210 showed no suppression of Als1p expression at a concentration of 0.002 g/ml (1/4ϫMIC), but the compound suppressed Als1p expression on the cell surface by 44%, 58%, and 74% at concentrations of 0.008 (1ϫMIC), 0.03 (4ϫMIC), and 0.13 g/ml (16ϫMIC), respectively. In contrast, micafungin further enhanced Als1p expression two-to threefold at concentrations above its MIC (0.016 g/ml). Fluconazole showed no effects on Als1p expression within the range of concentrations tested (0.03 to 2 g/ml). The effect of amphotericin B on Als1p expression was not estimated, since amphotericin B reduced the number of viable cells within 1 h.
In addition, the Als1p levels in the crude extracts of C. albicans cells treated with E1210 for 1 h were also investigated to exclude the possibility that the reduced levels of Als1p on the cell surface resulted from protein synthesis inhibition potentially due to E1210. E1210 tended to cause increases in Als1p levels in a concentration-dependent manner (Fig. 3 ), but these increases were not significant compared to the levels in the control cells. Furthermore, Rho1p expression on the surface of C. albicans IFM49971 cells grown for 1 h in MOPS-RPMI 1640 was also investigated. E1210 also showed no inhibition of Rho1p expression on the cell surface at concentrations tested (0.002 to 0.13 g/ml) ( Fig. 4) . These results suggested that the suppression of Als1p expression on the cell surface by E1210 does not result from Als1p synthesis inhibition and that GPI biosynthesis inhibition of E1210 leads to impairment of the maturation or translocation of GPIanchored proteins.
Effect of E1210 on C. albicans adherence. It was expected that E1210 could inhibit the adherence of C. albicans cells to polystyrene surfaces since E1210 inhibited the maturation of Als1p, an adhesin of C. albicans. C. albicans IFM49971 cells that were not incubated in MOPS-RPMI 1640 (0-h incubation) showed little adherence to polystyrene surfaces (2.9% Ϯ 0.6% of the level in control cells grown in MOPS-RPMI 1640 for 1 h). Figure 5 shows the effects of E1210 and other antifungals on the adherence of C. albicans cells to a polystyrene surface after incubation for 1 h. The adherence rate [(number of adherent cells/number of inoculated cells) ϫ 100] of untreated cells was 42.3% Ϯ 3.1%. E1210 inhibited the adherence of C. albicans cells in a concentrationdependent manner with an IC 50 of 0.0039 g/ml (95% CI, 0.0024 to 0.0063 g/ml), which was lower than its MIC (0.008 g/ml). No clumping was observed in nonadherent (planktonic) cells treated with E1210. Amphotericin B also inhibited C. albicans adherence in a concentration-dependent manner, but its IC 50 was 1.2 g/ml (95% CI, 0.79 to 1.9 g/ml), which was about 5-fold higher than its MIC (0.25 g/ml). Fluconazole showed little inhibition of C. albicans adherence within the range of concentrations tested (0.016 to 8 g/ml). In contrast, micafungin enhanced C. albicans adherence about 2-fold at concentrations above its MIC (0.016 g/ml). These results were consistent with the effects of these compounds on Als1p expression levels on the cell surface of C. albicans: E1210 reduced both Als1p expression on the cell surface and the adherence of cells to a polystyrene surface at concentrations above its MIC, while micafungin enhanced both, and fluconazole showed no effects.
Effect of E1210 on germ tube formation. The inhibitory effects of E1210 and other antifungals on germ tube formation in C. albicans IFM49971 cells were investigated (Fig. 6 ). E1210, micafungin, and amphotericin B inhibited germ tube formation by C. albicans with IC 50 s of 0.0071, 0.015, and 0.24 g/ml (95% CIs, 0.0054 to 0.0093, 0.014 to 0.016, and 0.20 to 0.29 g/ml), respectively, each of which was close to the respective MIC. No inhibition of germ tube formation was seen with fluconazole at concen- trations of Յ8 g/ml. Figure 7 shows micrographs of C. albicans cultures after treatment with E1210 and other antifungals. Indeed, E1210, micafungin, and amphotericin B showed concentrationdependent inhibition of the yeast-to-hypha transition and showed marked inhibition of germ tube formation at each MIC (Fig. 7) , whereas germ tube formation was observed even at a concentration of 8 g/ml for fluconazole ( Fig. 7) . Although others have reported that azole antifungals can inhibit germ tube formation (20, 65) , our observations were more consistent with those of Brayman and Wilks (5) . These discrepancies might be due to the use of different growth parameters, media, and/or C. albicans strains.
Effects of E1210 on the hyphal development of C. albicans were also evaluated in other hypha-inducing media: Spider medium, Lee's medium, YPD supplemented with 10% FCS, and YNB supplemented with 2.5 mM GlcNAc (Fig. 8) . E1210 suppressed the hyphal development of C. albicans in all media tested, but in Spider and Lee's media, some germinated cells were observed even at 4ϫMIC of E1210 ( Fig. 9 ) and the inhibition of the yeast-to-hypha transition in both media was milder than in MOPS-RPMI 1640 (Fig. 8) . Thus, E1210 inhibited the development of hyphal growth of C. albicans, but the compound also inhibited the yeast growth. The MIC of E1210 was 0.016 g/ml for cells cultured in YNB, which does not induce the hyphal growth of C. albicans.
Hyphal growth of C. albicans cells embedded in a matrix. Since growth of C. albicans cells embedded within a matrix promoted the formation of hyphae (6) , the morphology of cells growing in colonies in YPS agar medium was studied. Untreated cells (control) showed hyphal or filamentous growth when embedded in YPS agar for 48 h. E1210 suppressed hyphal growth at concentrations of 0.002 g/ml, but at 0.001 g/ml, filamentous but not highly elongated cells were observed ( Fig. 10 ). At 0.008 g/ml (1ϫMIC), E1210 inhibited hyphal and colony growth.
Biofilm formation. C. albicans biofilms were developed in MOPS-RPMI 1640 supplemented with 10% FCS after incubation for 24 h. Biofilm formation by C. albicans was assessed by a biofilm density assay using safranin staining of extracellular polymeric materials that the biofilm cells produced. The MICs of E1210, fluconazole, micafungin, and amphotericin B for C. albicans IFM49971 in MOPS-RPMI 1640 supplemented with 10% FCS were 0.016, 0.25, 0.06, and 0.25 g/ml, respectively. E1210 inhibited biofilm formation in a concentration-dependent manner with an IC 50 of 0.0044 g/ml (95% CI, 0.0037 to 0.0051 g/ml), which was 4-fold lower than its MIC, and almost entirely inhibited biofilm formation at a concentration of 0.008 g/ml (Fig. 11 ). Micafungin and amphotericin B also inhibited C. albicans biofilm formation in a concentration-dependent manner, and their IC 50 s were 0.014 g/ml (95% CI, 0.0052 to 0.038 g/ml) and 0.085 g/ml (95% CI, 0.076 to 0.095 g/ml), respectively. The inhibition curve of micafungin was not sigmoidal, and it inhibited biofilm formation even at the lowest concentrations tested. Fluconazole showed some inhibition of biofilm formation, with an IC 50 of 0.86 g/ml (95% CI, 0.53 to 1.4 g/ml), but did not completely inhibit biofilm formation even at the highest concentration tested (4 g/ml), which was 16 times higher than its MIC. C. albicans biofilms were observed by scanning electron microscopy (Fig. 12 ). The control (untreated) biofilms were composed of yeast, hyphal, and pseudohyphal elements; however, most of the exopolymeric materials (exopolysaccharides) were lost due to hydration during the procedures required for scanning electron microscopy (49) . E1210-treated cells were less hyphal, and the scanning electron micrograph revealed that E1210 inhibited the development of biofilm formation even at half of its MIC.
Since E1210 inhibited biofilm formation in C. albicans, we investigated the antifungal activity of E1210 against sessile cells of C. albicans. SMICs of E1210 for the 36 strains of C. albicans tested ranged from 0.016 to 0.25 g/ml ( Table 2 ). The SMIC 50 and SMIC 90 of E1210 were 0.03 and 0.13 g/ml, respectively, which were 4-to 8-fold greater than its MIC 50 and MIC 90 for planktonic cells. The activities of micafungin and amphotericin B against sessile cells were 8-fold lower than those against planktonic cells, but fluconazole's activity against sessile cells was Ͼ64-fold lower than the activity against planktonic cells. The in vitro activity of E1210 against sessile cells was almost the same as that of micafungin. These results suggested that E1210 should be active against C. albicans in biofilms.
DISCUSSION
In yeasts, GPIs are transferred to selected glycoproteins that are then transported to the plasma membrane, where they remain anchored to the outer surface of the plasma membrane via their GPI or become cross-linked to the cell wall (26) . Many proteins in the cell wall and plasma membrane involved in fungal cell wall synthesis and assembly are GPI anchored, and GPI synthesis and/or anchoring is essential for cell viability in yeasts (27, 29, 43, 46) . Although there is a GPI core structure (ethanolamine-P-6Man␣1-2Man␣1-6Man␣1-4GlcNH 2 ␣1-6-D-myo-inositol-1-phosphate-lipid, where the lipid is either diacylglycerol, acylalkylglycerol, or ceramide) which is conserved in all eukaryotes (26) , many subtle but significant differences that can occur as the result of additional species-specific modifications to the structure and assembly of GPI have been reported, leading to the notion that these could each be exploited as targets for new antifungal drugs (15, 17) . Some inhibitors of GPI biosynthesis have been reported (52, 57) , but most of these are designed based on acceptor analogs or protease inhibitors and do not possess drug-like properties. Serine protease inhibitors such as phenylmethylsulfonyl fluoride (PMSF) and diisopropyl fluoride inhibit ethanolamine phosphate addition and inositol acylation of GPI in Toxoplasma gondii and Trypanosoma brucei, which are suggested to have an activated serine that is absent in the other orthologues (56) . YW3548, a natural product, is thought to inhibit the addition of phosphoethanolamine (EtNP) to the first mannose of GPI, but it inhibits both yeast and mammalian GPI-EtNP transferases, although EtNP modification of the first mannose is not essential for the surface expression of GPI-anchored proteins on mammalian cells (22, 58) . We have modified the prototype compound BIQ (38, 59, 63) and developed E1210, which possesses potent antifungal activity (19, 34) . In this study, E1210 was shown to inhibit C. albicans and A. fumigatus Gwt1ps, which are suggested to be involved in the inositol acylation of GlcN-PI in the GPI biosynthesis pathway (36, 63, 64) , but not human Pig-Wp. In a large-scale survey of heterozygous mutants of C. albicans (69), Gwt1p was not a target of the existing antifungal compounds. This method could be useful for validating the target protein of E1210 in C. albicans. No inhibitors with sufficient fungal specificity and with properties that could lead to drug development have been reported to date. E1210 would be a first-in-class antifungal that acts by GPI biosynthesis inhibition.
Since most eukaryotes possess GWT1 orthologous genes and since there are several homologous regions in each Gwp1p (63, 70) , it is very interesting that E1210 possesses activity against Gwt1ps that is specific to fungi. Although the binding site of E1210 on fungal Gwt1ps remains unclear, E1210 might interact in part with the N-terminal end adjacent to the first homologous region of Gwt1ps, since a mutation in this region of ScGwt1p led to decreased susceptibility to BIQ (63) . The differences in the amino acid sequence of this region between fungi and mammals might confer the species specificity of Gwt1p to E1210. Virulence factors in C. albicans include proteins which mediate adherence to and invasion of host tissues, morphological changes from yeast to hyphae, secretion of lytic enzymes, maintenance of cell wall integrity, and avoidance of the host immune response (16) . Some of these virulence factors are GPI-anchored proteins, which comprise 88% of all covalently linked cell wall proteins in C. albicans (25) . Examples of GPI-anchored virulence factors are the Als protein family, adhesins with broad substrate specificity (15, 23, 55) ; Hwp1p, an epithelial adhesin and biofilm promoter (40); Eap1p, an adhesin to epithelial cells and polystyrene surfaces (30); secreted aspartyl proteinases Sap9p and Sap10p, phospholipase B Plb5p, and superoxide dismutases Sod4p, Sod5p, and Sod6p, which are also adhesins (2, 7, 32, 60) . Numerous GPI-anchored proteins have been identified as virulence factors in C. albicans; however, non-GPI-anchored proteins are also virulence factors (21) . Interactions involved with many proteins are necessary for pathogens to exhibit maximum virulence, but individual deletion of a number of proteins could alter the virulence phenotypes, such as adherence to surfaces and ligands. The compound that inhibits expression of one or more of these might affect surface function. As expected, E1210 suppressed the expression of Als1p on the cell surface of C. albicans, suggesting that E1210 inhibited GPI biosynthesis in C. albicans, resulting in the reduction of mature cell surface protein levels, which led to a reduction in the adherence potential of C. albicans, although this reduced adherence potential could not be due only to the reduced expression levels of Als1p. BIQ, a prototype Gwt1p inhibitor, also reduced the adherence of C. albicans to epithelial cells (63) . Since E1210 inhibited GPI biosynthesis, it could be expected that the compound would lead to impaired expression of all GPI-anchored proteins. Further validation will be required. In contrast, micafungin, a glucan synthase inhibitor, temporarily enhanced the Als1p levels on the cell surface and the adherence of C. albicans during a 1-h treatment. Since ␤-1,3-glucan biosynthesis is inhibited by micafungin, the cell surface protein levels might be increased so as to compensate for the osmotic pressure. However, micafungin is a fungicidal compound, and further treatment could lead to cell death.
Moreover, E1210 suppressed germ tube formation of C. albicans cells, indicating that E1210 could suppress hyphal growth of C. albicans. As the Als1p defect reduced adherence and hyphal growth of C. albicans (15, 55) , GPI biosynthesis inhibition is expected to lead to the suppression of hyphal growth and reduce adherence of C. albicans to host or material surfaces. The yeast-to-hypha transition inhibition by E1210 seems to occur as the result not of signal transduction inhibition but of the maturation inhibition of GPI-anchored proteins involved in cell wall assembly, such as via exo-1,3-glucanase (Exg2 and Spr1), ␤-1,6-glucan synthase (Kre1), transglycosidase (Crh1), ␤-1,3glucanosyltransferase (Phr1 and Phr2), and chitinase (Cht1 and Cht2) (7, 51) . However, micafungin suppressed germ tube formation even though it increased Als1p levels. The germ tube formation inhibition caused by micafungin is thought to result from inhibition of glucan chain extension (5) .
The expression of adhesins and the dimorphism of C. albicans have each been reported to be associated with biofilm formation (3, 41, 49) . E1210, which inhibited Als1p expression and germ tube formation, indeed showed substantial inhibition of biofilm formation. E1210 was as active against C. albicans in biofilms as micafungin and amphotericin B, which are fungicidal agents against C. albicans. The antifungal activity of E1210 is fungistatic (34) , but E1210 may be expected to indirectly kill Candida cells in hosts, since the deficiency of GPI reduced the resistance of C. albicans to macrophages (50).
Toenjes et al. (61) and Brayman and Wilks (5) have proposed that the yeast-to-hypha transition assay or germ tube formation assay should be used to identify signal transduction inhibitors or glucan synthase inhibitors. Since E1210 inhibits germ tube formation in C. albicans, the yeast-to-hypha transition assay might be a good tool for the identification of GPI biosynthesis inhibitors.
Thus, E1210 was suggested to inhibit the GPI biosynthesis, leading to the suppression of C. albicans hyphal growth, adherence, and biofilm formation. The GPI biosynthesis pathway has been investigated mainly in S. cerevisiae, but there are a few reports on C. albicans GPI, and some C. albicans mutants lacking the genes involved with GPI biosynthesis show contrariety in some phenotypes. The GPI7-null mutant showed reduced hyphal growth on solid media, increased sensitivity to Calcofluor white (CFW), reduced virulence in mice, and lytic action of macrophages (50) . The PGA1 mutant showed reduced adherence and biofilm formation and increased sensitivity to CFW but increased filamentation (18) . The conditional null mutation of GPI19 led to reduced surface GPI anchor levels, cell wall biogenesis aberrations (aggregation), and increased filamentation, but not increased CFW sensitivity (67) . The conditional null mutant of SMP3 exhibited reduced surface GPI anchor levels, aberrant morphology (aggregation of irregularly shaped cells), and increased CFW sensitivity (17) . Although GPI biosynthesis inhibition was not confirmed in the PGA1 mutant, it is surprising that each mutant unable to product mature GPI shows a different phenotype. In addition, from a large-scale survey of homozygously null mutants, GPI8 was suggested to be essential (11) , whereas a null mutant of GPI11 was viable (13), although both orthologous genes of S. cerevisiae are essential. Although the GWT1/gwt1 mutant showed a reduced growth rate, reduced hyphal development, and reduced virulence in mice, a gwt1/gwt1 null mutant was not obtained (unpublished data). This was probably because the GWT1 gene is essential in C. albicans. E1210 could exhibit growth inhibition through the GPI biosynthesis inhibition if so. Further studies on GPI biosynthesis of C. albicans are needed. Moreover, the majority of surface proteins in protozoans, such as T. brucei VSG, whose analysis led to the discovery of the GPI anchor, are GPI anchored, and GPI defects lead to lethality in these parasites, especially T. brucei (14, 37) . Since inositol acylation of GlcN-PI is a prerequisite for mannosylation and other subsequent modifications in other protozoans, such as Plasmodium falciparum, E1210 or a derivative of it could be active against these protozoans. However, mannosylation precedes inositol acylation in T. brucei, and inositol acyltransferase of T. brucei is inhibited by serine protease inhibitor PMSF and GlcN-(2-O-alkyl) PI analogs, which do not inhibit the inositol acyltransferases of mammals and fungi (52, 57, 52) . Trypanosoma might possess inositol acyltransferases different from those of other eukaryotes. The activity of Gwt1p inhibitors against protozoans should therefore also be studied.
The antifungal characteristics of E1210 are fascinating, and further studies leading to its clinical development, including mode-of-action studies, are warranted.
